DrugDashboards

Bendamustine Hydrochloride

Bendamustine Hydrochloride · BENDAMUSTINE HYDROCHLORIDE 100 mg/20mL · Injection, Powder, Lyophilized, For Solution · Intravenous · Eugia US LLC

NDC 55150-0392-01 · 1 VIAL, SINGLE-DOSE in 1 CARTON / 20 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →

The short version

4 companies supply this market — a reasonable cushion if one runs into trouble.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$550.00
Reported to Texas DSHS · 2026 annual filing · Eugia Us Llc

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 1 MG
$2.960
HCPCS J9033 · Jul 1, 2026 quarter · typically ASP + 6%

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA214739
TE code
AP
Approval date
Jun 5, 2023
Patents / exclusivity
None on file

Shortage history

  • Planned discontinuation — Treanda, Injection, Solution, 25 mg/5 mL, 1 vial, Single-Dose in 1 carton (NDC 63459-390-08)Jul 23, 2026

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Bendamustine Hydrochloride (Injection, Powder, Lyophilized, For Solution)

LabelerStrengthFirst seenLast seen
Accord Healthcare, Inc.BENDAMUSTINE HYDROCHLORIDE 100 mg/20mLJul 15, 2026Sep 2, 2026
Accord Healthcare, Inc.BENDAMUSTINE HYDROCHLORIDE 25 mg/5mLJul 15, 2026Sep 2, 2026
BluePoint LaboratoriesBENDAMUSTINE HYDROCHLORIDE 100 mg/20mLJul 15, 2026Sep 2, 2026
Cephalon, LLCBENDAMUSTINE HYDROCHLORIDE 25 mg/5mLJul 15, 2026Sep 2, 2026
Cephalon, LLCBENDAMUSTINE HYDROCHLORIDE 100 mg/20mLJul 15, 2026Sep 2, 2026
Eugia US LLCBENDAMUSTINE HYDROCHLORIDE 100 mg/20mLJul 15, 2026Sep 2, 2026
Eugia US LLCBENDAMUSTINE HYDROCHLORIDE 25 mg/5mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Bendamustine Hydrochloride — NDC 55150-0392-01," retrieved September 3, 2026, https://drugdashboards.com/drug/55150039201.

Free to cite with attribution — see how the data is put together.